Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19.

Busch, Matthias H; Timmermans, Sjoerd A M E G; Van Kuijk, Sander M J; Aendekerk, Joop P; Ysermans, Renée; Van Doorn, Daan P C; Potjewijd, Judith; Van de Poll, Marcel C G; Van der Horst, Iwan C C; Damoiseaux, Jan G M C; Spronk, Henri M H; Cate, Hugo Ten; Reutelingsperger, Chris P; Nagy, Magdolna; Van Paassen, Pieter

Busch, Matthias H; Timmermans, Sjoerd A M E G; Van Kuijk, Sander M J; Aendekerk, Joop P; Ysermans, Renée; Van Doorn, Daan P C; Potjewijd, Judith; Van de Poll, Marcel C G; Van der Horst, Iwan C C; Damoiseaux, Jan G M C; Spronk, Henri M H; Cate, Hugo Ten; Reutelingsperger, Chris P; Nagy, Magdolna; Van Paassen, Pieter.

Busch MH; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Timmermans SAMEG; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Van Kuijk SMJ; Dept. of Clinical Epidemiology and Medical Technology Assessment.
Aendekerk JP; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Ysermans R; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Van Doorn DPC; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Potjewijd J; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Van de Poll MCG; Dept. Intensive Care Medicine.
Van der Horst ICC; Dept. Intensive Care Medicine.
Damoiseaux JGMC; Central Diagnostic Laboratory.
Spronk HMH; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Thrombosis Expertise Center, Maastricht University Medical Center, Maastricht.
Cate HT; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Thrombosis Expertise Center, Maastricht University Medical Center, Maastricht.
Reutelingsperger CP; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Nagy M; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht.
Van Paassen P; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht. p.vanpaassen@maastrichtuniversity.nl.

Haematologica ; 108(5): 1417-1422, 2023 05 01.

Artículo en Inglés | MEDLINE | ID: covidwho-2313296

Asunto(s)

COVID-19; Enfermedades de von Willebrand; Humanos; Factor de von Willebrand/metabolismo; Trombina/metabolismo; Coagulación Sanguínea; Factor VIII/metabolismo; Gravedad del Paciente

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Enfermedades de von Willebrand / COVID-19 Tipo de estudio: Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: Haematologica Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google